COA / COA-2026-0206
NAD+ 500 mg
Lot COA-2026-0206
99.82% (3-vial average)HPLC
Report date
2026-09-03
Testing lab
AV Analytics
Appearance
Lyophilized
| Analyte | Method | Result |
|---|---|---|
| Purity | UPLC-UV + UPLC-MS | 99.82% (3-vial average) |
| Identity | UPLC-UV + UPLC-MS | Conforms (UPLC-MS ionization profile match) |
| Net peptide content | UPLC-UV + UPLC-MS | 502.67 / 500.99 / 501.96 mg (3 vials) |
| Endotoxin | LAL, USP <85> | Pass (rFC, <0.5 EU/mL; vials 0.13/0.05/0.09) |
Independent analysis by AV Analytics. Results apply to the stated lot. For laboratory and research use only — not for human or animal consumption.